Fee-shifting may have been overtaken by the future of the IPR regime as the most sensitive topic on the US patent reform agenda, but it remains one of the most politically loaded parts of the proposed legislation. For Republicans who hunger for…
A new report from the McKinsey Global Institute (MGI) examining China’s innovation record confirms that despite gains made in consumer electronics offerings, Chinese companies are struggling to bring technologies to market in many science and…
As Europe reels from deepening financial turmoil, another potential economic catastrophe is unfolding on the other side of the world.
For several months now, China’s capital markets have been experiencing chaos the likes of which has rarely been…
The buyer, Amperex Technology Limited, is facing a US patent suit and ITC investigation from LG Chem. The portfolio of former Motorola assets had been on the market since 2015.
The August edition of our monthly round-up of the life sciences stories you need to know
Company now faces possibility of £500 million pay-out to the NHS, while ruling could also make second medical use patents harder to obtain and easier to invalidate
Company - whose IP function is headed by former Accenture and Rambus exec Wayne Sobon - has launched a spate of infringement suits in US district court and brought two actions at the ITC
The landmark judgment makes it harder for pharmaceutical companies to use what has become an important source of protection – so opening the way for more generic competition
Law and attorney firms from around the world recognised for their outstanding work in litigation, prosecution and transactions during 2018
Patent office officials in Beijing reveal the country's top patent recipients, amount of cross-border royalty flows and ambiguous data on foreign firms' patenting activity
Chaya Chandavasu, senior vice president for science and innovation at PTT Global Chemical, explains how IP strategy has helped the subsidiary of Thailand's state-owned oil and gas giant better understand its technology space and attract joint venture partners
A pair of acquisitions and the bankruptcy of a competitor opened the door for Hanwha Q CELLS to move from licensee to plaintiff in the latest indication that disputes in the clean energy sector are heating up
A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them
The Japanese automaker is ‘opening up’ patents related to hybrid electric vehicle technology that it has previously licensed to Nissan, Ford, Subaru and Mazda, in a move that expands on its previous fuel cell pledge
Our week-long series on the US-China trade dispute concludes, as deal-makers working on the ground say licence transactions and tech transfer are still happening, but big uncertainties remain